Observational studyThoracic cancer2026

Interstitial Lung Disease in Patients With Unresectable Stage III NSCLC Treated With Chemoradiotherapy Followed by Durvalumab in Japan: Analysis From the Multicenter Prospective AYAME Study.

Nobuyuki Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.